68 related articles for article (PubMed ID: 27483243)
21. Synthesis, Crystal Study, and Anti-Proliferative Activity of Some 2-Benzimidazolylthioacetophenones towards Triple-Negative Breast Cancer MDA-MB-468 Cells as Apoptosis-Inducing Agents.
Abdel-Aziz HA; Eldehna WM; Ghabbour H; Al-Ansary GH; Assaf AM; Al-Dhfyan A
Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27483243
[TBL] [Abstract][Full Text] [Related]
22. One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDA-MB-231 cells.
Eldehna WM; El-Naggar DH; Hamed AR; Ibrahim HS; Ghabbour HA; Abdel-Aziz HA
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):309-318. PubMed ID: 29281924
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosis-inducing agents.
Eldehna WM; Almahli H; Al-Ansary GH; Ghabbour HA; Aly MH; Ismael OE; Al-Dhfyan A; Abdel-Aziz HA
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):600-613. PubMed ID: 28173708
[TBL] [Abstract][Full Text] [Related]
24. Novel Thiazolidinone/Thiazolo[3,2-
El-Naggar M; Eldehna WM; Almahli H; Elgez A; Fares M; Elaasser MM; Abdel-Aziz HA
Molecules; 2018 Jun; 23(6):. PubMed ID: 29895744
[TBL] [Abstract][Full Text] [Related]
25. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
[TBL] [Abstract][Full Text] [Related]
26. Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells.
Varghese E; Samuel SM; Varghese S; Cheema S; Mamtani R; Büsselberg D
Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30563138
[TBL] [Abstract][Full Text] [Related]
27. Development of certain new 2-substituted-quinazolin-4-yl-aminobenzenesulfonamide as potential antitumor agents.
Alafeefy AM; Ahmad R; Abdulla M; Eldehna WM; Al-Tamimi AM; Abdel-Aziz HA; Al-Obaid O; Carta F; Al-Kahtani AA; Supuran CT
Eur J Med Chem; 2016 Feb; 109():247-53. PubMed ID: 26774930
[TBL] [Abstract][Full Text] [Related]
28. 2-((Benzimidazol-2-yl)thio)-1-arylethan-1-ones: Synthesis, crystal study and cancer stem cells CD133 targeting potential.
Abdel-Aziz HA; Ghabbour HA; Eldehna WM; Al-Rashood ST; Al-Rashood KA; Fun HK; Al-Tahhan M; Al-Dhfyan A
Eur J Med Chem; 2015 Nov; 104():1-10. PubMed ID: 26413725
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of 2-aryl-1,2,4-oxadiazolo-benzimidazoles: Tubulin polymerization inhibitors and apoptosis inducing agents.
Kamal A; Reddy TS; Vishnuvardhan MVPS; Nimbarte VD; Subba Rao AV; Srinivasulu V; Shankaraiah N
Bioorg Med Chem; 2015 Aug; 23(15):4608-4623. PubMed ID: 26169762
[TBL] [Abstract][Full Text] [Related]
30. Established breast cancer risk factors and risk of intrinsic tumor subtypes.
Barnard ME; Boeke CE; Tamimi RM
Biochim Biophys Acta; 2015 Aug; 1856(1):73-85. PubMed ID: 26071880
[TBL] [Abstract][Full Text] [Related]
31. Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking.
Eldehna WM; Fares M; Ibrahim HS; Aly MH; Zada S; Ali MM; Abou-Seri SM; Abdel-Aziz HA; Abou El Ella DA
Eur J Med Chem; 2015 Jul; 100():89-97. PubMed ID: 26071861
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and in vitro antiproliferative activity of novel isatin-quinazoline hybrids.
Fares M; Eldehna WM; Abou-Seri SM; Abdel-Aziz HA; Aly MH; Tolba MF
Arch Pharm (Weinheim); 2015 Feb; 348(2):144-54. PubMed ID: 25664631
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of arylpyrazole linked benzimidazole conjugates as potential microtubule disruptors.
Kamal A; Shaik AB; Polepalli S; Kumar GB; Reddy VS; Mahesh R; Garimella S; Jain N
Bioorg Med Chem; 2015 Mar; 23(5):1082-95. PubMed ID: 25648686
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents.
Eldehna WM; Altoukhy A; Mahrous H; Abdel-Aziz HA
Eur J Med Chem; 2015 Jan; 90():684-94. PubMed ID: 25499988
[TBL] [Abstract][Full Text] [Related]
35. Structure activity relationship (SAR) study of benzimidazole scaffold for different biological activities: A mini-review.
Yadav G; Ganguly S
Eur J Med Chem; 2015 Jun; 97():419-43. PubMed ID: 25479684
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
